CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system

Viral Immunology

Volumn 20, Issue 4, 2007, Pages 599-608

  Hickey, Michelle J ^a   Held, Katherine S ^a   Baum, Elizabeth ^a   Gao, Ji Liang ^b   Murphy, Philip M ^b   Lane, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC DISEASE; CONTROLLED STUDY; CYTOLYSIS; DEMYELINATING DISEASE; FATALITY; HOST RESISTANCE; INFECTION SENSITIVITY; MACROPHAGE; MALE; MORBIDITY; MORTALITY; MOUSE; MULTIPLE SCLEROSIS; MURINE HEPATITIS CORONAVIRUS; NEUROPATHOLOGY; NONHUMAN; SIGNAL TRANSDUCTION; SURVIVAL; T LYMPHOCYTE; VIRUS ENCEPHALITIS; VIRUS INFECTION; WILD TYPE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CORONAVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; ENCEPHALITIS, VIRAL; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MURINE HEPATITIS VIRUS; RECEPTORS, CCR1; T-LYMPHOCYTES;

CORONAVIRUS; MURINE HEPATITIS VIRUS; MUS;

EID: 37549061743     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0056     Document Type: Article

References (39)

1. Asensio VC, and Campbell IL: Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 1997;71:7832-7840.
2. Bendall L: Chemokines and their receptors in disease. Histol Histopathol 2005;20:907-926.
3. Bergmann CC, Lane TE, and Stohlman SA: Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 2006;4:121-132.
4. Cho C, and Miller RJ: Chemokine receptors and neural function. J Neurovirol 2002;8:573-584.
5. Combadiere C, Ahuja SK, Van Damme J, Tiffany HL, Gao JL, and Murphy PM: Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 1995;270:29671-29675.
6. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, and Luster AD: IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168:3195-3204.
7. Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, and Weiner LP: Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 1986;58:869-875.
8. Gao JL, Kuhns DB, Tiffany HL, McDermott D, Li X, Francke U, and Murphy PM: Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor. J Exp Med 1993;177:1421-1427.
9. Gao JL, Wynn TA, Chang Y, et al.: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997;185:1959-1968.
10. Glass WG, Chen BP, Liu MT, and Lane TE: Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol 2002;15:261-272.
11. Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, and Lane TE: Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 2004;172: 4018-4025.
12. Glass WG, and Lane TE: Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system. Virology 2003;312:407-414.
13. Glass WG, and Lane TE: Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease. J Virol 2003;77: 191-198.
14. Glass WG, Liu MT, Kuziel WA, and Lane TE: Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 2001;288:8-17.
15. Held KS, Chen BP, Kuziel WA, Rollins BJ, and Lane TE: Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology 2004;329:251-260.
16. Hirano N, Murakami T, Fujiwara K, and Matsumoto M: Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn J Exp Med 1978;48:71-75.
17. Hoffman LM., Fife BT, Begolka WS, Miller SD, and Karpus WJ: Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J Neurovirol 1999;5:635-642.
18. Houtman JJ, and Fleming JO: Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol 1996;2:101-110.
19. Houtman JJ, and Fleming JO: Pathogenesis of mouse hepatitis virus-induced demyelination. J Neurovirol 1996;2: 361-376.
20. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, and Buchmeier MJ: Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998;160:970-978.
21. Lane TE, and Buchmeier MJ: Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol 1997;5:9-14.
22. Lane TE, Fox HS, and Buchmeier MJ: Inhibition of nitric oxide synthase-2 reduces the severity of mouse hepatitis virus-induced demyelination: implications for NOS2/NO regulation of chemokine expression and inflammation. J Neurovirol 1999;5:48-54.
23. Lane TE, Liu MT, Chen BP, et al.: A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 2000;74:1415-1424.
24. Lin MT, Hinton DR, Marten NW, Bergmann CC, and Stohlman SA: Antibody prevents virus reactivation within the central nervous system. J Immunol 1999;162:7358-7368.
25. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, and Lane TE: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 2000;165: 2327-2330.
26. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Hamilton TA, Armstrong DA, and Lane TE: The CXC chemokines IP-10 and Mig are essential in host defense following infection with a neurotropic coronavirus. Adv Exp Med Biol 2001;494:323-327.
27. Liu MT, Keirstead HS, and Lane TE: Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 2001;167: 4091-4097.
28. Luther SA, and Cyster JG: Chemokines as regulators of T cell differentiation. Nat Immunol 2001;2:102-107.
29. Marten NW, Stohlman SA, and Bergmann CC: MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol 2001;14:1-18.
30. Miller AL, Gerard C, Schaller M, Gruber AD, Humbles AA, and Lukacs NW: Deletion of CCR1 attenuates pathophysiologic responses during respiratory syncytial virus infection. J Immunol 2006;176:2562-2567.
31. Moser B, and Loetscher P: Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-128.
32. Neote K, DiGregorio D, Mak JY, Horuk R, and Schall TJ: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72:415-425.
33. Ramakrishna C, Bergmann CC, Atkinson R, and Stohlman SA: Control of central nervous system viral persistence by neutralizing antibody. J Virol 2003;77:4670-4678.
34. Raport CJ, Gosling J, Schweickart VL, Gray PW, and Charo IF: Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 1996; 271:17161-17166.
35. Tanabe S, Heesen M, Berman MA, Fischer MB, Yoshizawa I, Luo Y, and Dorf ME: Murine astrocytes express a functional chemokine receptor. J Neurosci 1997;17:6522-6528.
36. Trifilo MJ, Bergmann CC, Kuziel WA, and Lane TE: CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J Virol 2003;77:4004-4014.
37. Williamson JS, and Stohlman SA. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol 1990;64: 4589-4592.
38. Wu GF, Dandekar AA, Pewe L, and Perlman S: CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000;165:2278-2286.
39. Wu GF, and Perlman S: Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol 1999;73:8771-8780.